Truvian is a healthcare company automating a benchtop system to produce lab-accurate results for a full-suite of health tests using a small sample of blood, providing immediate insights to inform healthcare decisions.
Truvian Sciences does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.
The stock price for Truvian Sciences will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).
| Date | Funding Round | Funding Raised | Price per Share | IPO Valuation |
|---|---|---|---|---|
| 2/24/2021 | Series C | $410.51MM | $XXX.XX | $XXX.XX |
| 11/20/2019 | Series B | $138.87MM | $XXX.XX | $XXX.XX |
| 1/1/2019 | Series A | $32.2MM | $XXX.XX | $XXX.XX |
| 9/28/2015 | Series Seed | $5.71MM | $XXX.XX | $XXX.XX |
